SEC Tracker
Get the app

PDS Biotechnology PDSB

PDS Biotechnology hosts KOL event on PDS0301 for liver cancer

Form
8-K
Filed
Importance
Routine
  1. Event on Oct 15, 2026
  2. Features Dr. Jonathan Hernandez
  3. Focus on mCRC cohort
  4. Discusses PDS0301 Phase 2 trials

Written from the 8-K on EDGAR. Check the filing before you rely on it.

Open in the appGet the appView on EDGAR

Get an email when PDS Biotechnology files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2834 and related industry codes: the same peer list as the financial tables.

  1. Sutro Biopharma STRO public float $60M, Jun 30, 2025
  2. Medicinova MNOV public float $62M, Jun 30, 2025
  3. iBio IBIO public float $58M, Dec 31, 2025
  4. Lifevantage LFVN public float $64M, Dec 31, 2025
  5. Veru VERU public float $64M, Mar 31, 2025, over 18 months old